Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Dual-time-point [F]FDG-PET/CT as a prognostic biomarker in patients with pleural mesothelioma undergoing immunotherapy
Saved in:
| Published in: | EJNMMI Research |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Dual-time-point [F]FDG-PET/CT as a prognostic biomarker in patients with pleural mesothelioma undergoing immunotherapy
- Toward reproducible metabolic tumor volume quantification in endometrial cancer: optimizing [¹⁸F]FDG PET/CT tumor segmentation methods
- Subcutaneous injection of semaglutide causes increased muscle uptake of F-FDG and reduces the imaging quality of PET/CT: a case report
- [F]FDG PET/CT is a quantitative tool to probe vascular inflammation and immune system metabolic activation in atherosclerotic nonhuman primates
- Head to head comparison of [Ga]Ga-FAPI-04 and [F]FDG PET/CT in the diagnosis and staging of pancreatic cancer: a prospective study
- Complementary roles of 68Ga-FAPI and 18 F-FDG PET/CT in evaluating IgG4-related disease: a systematic review and pooled analysis
- Evaluating TB treatment responses by [18F]FDG-PET/CT imaging